Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Biopsy is crucial for diagnosing unusual hair loss causes like lymphoma.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Clonally expanded CD8+ T cells cause alopecia areata.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Immune cells affect hair growth and could lead to new hair loss treatments.